Genomtec S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GMT.WA research report →
About the company
Genomtec S. A. , established in 2016 and based in Wroclaw, Poland, is dedicated to the research, development, manufacturing, and global commercialization of advanced molecular diagnostic products.
- CEO
- Miron Tokarski
- IPO
- 2021
- Employees
- 17
- HQ
- Wroclaw, PL
Price Chart
- Market Cap
- $72.01M
- P/E
- -7.51
- P/S
- 2250.28
- P/B
- 10.26
- EV/EBITDA
- -6.74
- Div Yield
- 0.00%
- Gross Margin
- -31709.38%
- Op Margin
- -45118.75%
- Net Margin
- -29443.75%
- ROE
- -95.46%
- ROIC
- -139.46%
- Revenue
- $21.00K · 2000.00%
- Net Income
- $-10,431,000 · 6.93%
- EPS
- $-0.69 · 17.86%
- Op Income
- $-14,778,000
- FCF YoY
- -69.39%
- 52W High
- $7.33
- 52W Low
- $3.25
- 50D MA
- $5.14
- 200D MA
- $5.12
- Beta
- 0.29
- Avg Volume
- 42.01K
Get TickerSpark's AI analysis on GMT.WA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our GMT.WA coverage
Recent articles, reports, and earnings notes.
No research on GMT.WA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GMT.WA report →Similar companies
Peers in the same neighborhood.